PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
226.29 - 230.79
161.38 - 242.52
38.50M / 42.21M (Avg.)
34.73 | 6.57
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-22.14%
Negative net income growth while JD stands at 10.51%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
6.25%
D&A growth of 6.25% while JD is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
-1900.00%
Negative yoy deferred tax while JD stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-13.00%
Negative yoy SBC while JD is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-157.21%
Negative yoy working capital usage while JD is 0.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
189.19%
AR growth of 189.19% while JD is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
194.41%
Inventory growth of 194.41% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-184.81%
Negative yoy AP while JD is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-119.82%
Negative yoy usage while JD is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-22.08%
Both negative yoy, with JD at -301.39%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-142.07%
Both yoy CFO lines are negative, with JD at -173.37%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-2.19%
Negative yoy CapEx while JD is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-2000.00%
Negative yoy acquisition while JD stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
41.90%
Purchases growth of 41.90% while JD is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
26.74%
Liquidation growth of 26.74% while JD is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-100.00%
We reduce yoy other investing while JD is 248.67%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
66.29%
Lower net investing outflow yoy vs. JD's 230.06%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
52.34%
Debt repayment growth of 52.34% while JD is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Buyback growth of 100.00% while JD is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.